The staining of liver sections indicated that the CYN-treated group showed less steatosis, a lower percentage of sirius red staining in interstitial liver tissue, reduced perivascular collagen expression, and decreased α-SMA expression compared with the blank group. The gene discussed is ACTA1; the disease is steatosis.